(NAFB) — Elanco Animal Health has entered into a $7.6 billion agreement with Bayer to acquire its animal health business in a transaction valued at $7.6 billion. The transaction, which is subject to regulatory approval, will double Elanco’s companion animal business. Bayer CEO Werner Baumann says the acquisition by Elanco will “give rise to a leading competitor in the animal …
Nematode Control Increases Cotton Yield Potential
For cotton growers battling nematodes, University trials across the South continue to show an increase in yield and profit with an at-plant nematicide application. And according to Bayer Senior Technical Service Representative, Keith Rucker, cotton fields treated with Velum® Total have an advantage. At-plant nematode control increases cotton yield potential Velum® Total nematicide protects root system to boost potential yields University trials across …
Glyphosate Discussed by Perdue in Washington
We’ve all heard about the various lawsuits claiming glyphosate causes cancer, with two of those cases recently seeing juries awarding large amounts to those who had filed suits against the product Roundup. Bayer just announced they’ve released more than 100 studies on the safety profile of glyphosate, which includes crop protection safety studies as part of being more transparent following their acquisition …
Bayer “Farm for Good” Program
The Crop Science Division of Bayer is inviting Southern growers to take part in their Farm for Good™ Sweepstakes, where you could win a $5,000 donation to the local charity of your choice. Farm for Good donations will be awarded to 10 growers from the Southern states for a total of $50,000 in charitable donations to benefit organizations in grower communities. Keith Rucker, Technical Service …
California Judge Reduces RoundUp Damage Award
A California Judge reduced the more than $200 million award to less than $40 million in a case against Bayer AG’s Roundup herbicide, formally of Monsanto. Dow Jones reports a San Francisco Superior Court Judge said the $250 million in punitive damages awarded by the jury must be slimmed down to match the $39.25 million in compensatory damages that the …
Bayer Files Appeal to California Glyphosate Ruling
Bayer is increasing efforts to defend Roundup, its flagship weed killer. A Dow Jones report says the effort follows a recent verdict in a California court case alleging that the chemical causes cancer sent shares sharply lower. According to the company’s court filing, Bayer wants a California judge to overturn the jury verdict, order a new trial, or reduce the …
Bayer Says Dicamba Decision Likely Coming Soon
The world’s largest agribusiness is predicting the Environmental Protection Agency will decide soon on the future of dicamba. Bayer expects the EPA to issue a renewal and an updated license for the product in the weeks ahead. Liam Condon, President of the Crop Science Division at Bayer, says, “The EPA wants to make a decision before the next growing season …
Glyphosate Lawsuits Numbers Climbing
Bayer AG says the number of lawsuits against glyphosate is rising, adding to concerns about potentially lengthy and costly litigation. Bayer, which recently completed its acquisition of Monsanto, lowered its full-year earnings outlook stemming from delays in closing the deal. Bayer is now integrating the maker of Roundup, which contains glyphosate, into its company. The California lawsuit which set a …
Environmental Groups Urge EPA to Revoke Dicamba Approval
Environmental groups are using the courts to argue against renewing approval of dicamba. The groups are arguing that the Environmental Protection Agency (EPA) failed to analyze the risks of now Bayer’s dicamba-based weed killer posed to nearby crops before approving it in 2016, according to Reuters. Monsanto, a unit of Bayer, urged the court to dismiss the lawsuit. Bayer expects …
Bayer CEO Says Monsanto Merger Still a Win-Win
Werner Baumann, Bayer Chief Executive Officer, tried to soothe the frayed nerves of investors after a recent jury award of $289 million during a trial regarding glyphosate. Baumann says the merger between Bayer and Monsanto still makes sense in spite of the challenges ahead. Baumann told a German newspaper that there is “no reason to break out in nervousness” in …